NCT05332106View on ClinicalTrials.gov

Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 12, 2022

Primary Completion Date

March 22, 2022

Study Completion Date

March 22, 2022

Conditions
Bioequivalence
Interventions
DRUG

Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet

Investigational Medicinal Product

DRUG

Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet

Climodien (Bayer plc.)

Trial Locations (1)

600048

Azidus Laboratories Ltd., Chennai

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT05332106 - Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter